The headline is generic drugs should be cheap, but Insurers are Charging Thousands of dollars for them. It's an article dated September 2023 by Joseph Walker. Let me read a couple of sentences. It starts out by saying The cancer drug Gleevec went generic in 2016 and can be bought today for as little as $55 a month. But many patients insurance plans are paying more than 100 times that. CVS Health and Cigna charge $6,600 a month or more for Gleevec prescriptions. A Wall Street Journal analysis of pricing data found they are able to do that because they set the prices with pharmacies, which they sometimes own. (00:36–01:00)
CLAIM
Asserts that insurance plans charge significantly more for Gleevec than its generic cost.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
